Private equity sponsors have injected more than $2.5bn into at least 165 distressed mid-market portfolio companies over the past five years, but only a small minority see lasting credit improvement, according to a report by Bloomberg citing new research from S&P Global Ratings.
The median sponsor contribution of around $10m typically extends liquidity by just seven months, with more than a third of companies eventually defaulting and roughly 40% remaining rated triple-C. Fewer than a quarter show meaningful recovery in debt-servicing ability.
S&P analysts note that while equity injections can temporarily stabilise operations and offer lenders a cushion, they often fail to address underlying issues such as high leverage or structural shifts in demand. In some cases, sponsor manoeuvres in restructuring talks can add complexity and heighten bankruptcy risk.
The report highlights that private credit deals, with tighter covenants, may provide a more effective framework for sponsor-led rescue plans compared with broadly syndicated loans.
